Language selection

Search

Biomanufacturing: Projects underway


Government of Canada investments of more than $1.2B in 28 COVID‑19 domestic biomanufacturing, vaccines and therapeutics projects


View the information on an interactive map

Last modified: May 18, 2021

National

The Government of Canada has invested in research projects across Canada through important granting partners like the Canadian Institutes for Health Research. For the complete list of investments including research please consult the Government of Canada investments in biomanufacturing, development of COVID-19 vaccines and therapeutics, and research.


Alberta

Total investments

$14,900,000

Numbers of projects

2

Number of investments

3

Description of investments

Entos Pharmaceuticals (Edmonton, Alberta)

Entos Pharmaceuticals

Related link:

Providence Therapeutics and Northern RNA Inc. (Calgary, Alberta)

Providence Therapeutics and Northern RNA Inc.

Related links:


Atlantic

Total investments

$9,400,000

Numbers of projects

1

Number of investments

3

Description of investments

IMV Inc. (Dartmouth, Nova Scotia)

IMV Inc.

Related links:


British Columbia

Total investments

$222,009,764

Numbers of projects

5

Number of investments

6

Description of investments

AbCellera Biologics (Vancouver, British Columbia)

AbCellera Biologics

Related links:

Bold Therapeutics (Vancouver, British Columbia)

Bold Therapeutics

Related link:

Precision NanoSystems Inc. (Vancouver, British Columbia)

Precision NanoSystems Inc.

Related links:

Symvivo (Burnaby, British Columbia)

Symvivo

Qu Biologics (Vancouver, British Columbia)

Qu Biologics

Related links:


Ontario

Total investments

$314,035,000

Numbers of projects

9

Numbers of investments

9

Description of investments

Arch Biopartners (Toronto, Ontario)

Arch Biopartners

Related link:

Edesa Biotech (Markham, Ontario)

Edesa Biotech

Related link:

Hypermabs Inc. (Toronto, Ontario)

Hypermabs Inc.

Mannin Research Inc. (Toronto, Ontario)

Mannin Research Inc.

Novocol Pharmaceutical of Canada (Cambridge, Ontario)

Novocol Pharmaceutical of Canada

Related links

Resilience Biotechnologies Inc. (RBI) (Mississauga, Ontario)

Resilience Biotechnologies Inc. (RBI) 

Related links

Stem Cell Network (Ottawa, Ontario)

Stem Cell Network

Related link:

Variation Biotechnologies Inc. (VBI) (Ottawa, Ontario)

Variation Biotechnologies Inc. (VBI)

Related link:

Vasomune Therapeutics Inc. (Toronto, Ontario)

Vasomune Therapeutics Inc.


Quebec

Total investments

$424,706,796

Numbers of projects

10

Number of investments

10

Description of investments

Biodextris Inc. (Laval, Quebec)

Biodextris Inc.

Related link:

Glycovax Pharma (Montréal, Quebec)

Glycovax Pharma

Related link:

Immune Biosolutions (Sherbrooke, Quebec)

Immune Biosolutions

Related link:

JN Nova Pharma (Montréal, Quebec)

JN Nova Pharma

Related link:

KABS Laboratories Inc. (Saint-Hubert, Quebec)

KABS Laboratories Inc.

Related link:

Laurent Pharmaceuticals (Montréal, Quebec)

Laurent Pharmaceuticals

Related link:

Medicago (Québec, Quebec)

Medicago

Related link:

Novavax (Montréal, Quebec)

Novavax

Related link:

NRC Royalmount (BMC) (Montréal, Quebec)

NRC Royalmount (BMC)

NRC Royalmount - Clinical Trial Material Facility (CTMF) (Montréal, Quebec)

NRC Royalmount - Clinical Trial Material Facility (CTMF)


Saskatchewan

Total investments

$47,300,000

Numbers of projects

1

Number of investments

4

Description of investments

Vaccine and Infectious Disease Organization (VIDO) (Saskatoon, Saskatchewan)

Vaccine and Infectious Disease Organization (VIDO)

Related links:


Planning for the future

In addition to biomanufacturing capacity, our investments will ensure that, in the long term, Canada has the talent, a research and development pipeline, robust SMEs and security across the supply chain to support a dynamic and growing biologics manufacturing and innovation ecosystem.

Work is under way to assess current and ongoing needs in the biomanufacturing sector and to find ways to complement recent government investments—such as those made through the Strategic Innovation Fund (SIF) and the National Research Council of Canada's Industrial Research Assistance Program (NRC IRAP).

Complete list of Government of Canada investments in COVID-19 vaccines and biomanufacturing capacity:

Date modified: